260 related articles for article (PubMed ID: 30847510)
1. Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.
Berghausen EM; Feik L; Zierden M; Vantler M; Rosenkranz S
Herz; 2019 Apr; 44(2):130-137. PubMed ID: 30847510
[TBL] [Abstract][Full Text] [Related]
2. Perivascular Inflammation in Pulmonary Arterial Hypertension.
Hu Y; Chi L; Kuebler WM; Goldenberg NM
Cells; 2020 Oct; 9(11):. PubMed ID: 33105588
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening.
Liu SF; Nambiar Veetil N; Li Q; Kucherenko MM; Knosalla C; Kuebler WM
Front Immunol; 2022; 13():959209. PubMed ID: 36275740
[TBL] [Abstract][Full Text] [Related]
4. The role of immune cells in pulmonary hypertension: Focusing on macrophages.
Luo P; Qiu B
Hum Immunol; 2022 Feb; 83(2):153-163. PubMed ID: 34844784
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension.
El Chami H; Hassoun PM
Compr Physiol; 2011 Oct; 1(4):1929-41. PubMed ID: 23733693
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.
Rabinovitch M; Guignabert C; Humbert M; Nicolls MR
Circ Res; 2014 Jun; 115(1):165-75. PubMed ID: 24951765
[TBL] [Abstract][Full Text] [Related]
7. Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.
Liang S; Desai AA; Black SM; Tang H
Adv Exp Med Biol; 2021; 1303():275-303. PubMed ID: 33788198
[TBL] [Abstract][Full Text] [Related]
8. An Hb-mediated circulating macrophage contributing to pulmonary vascular remodeling in sickle cell disease.
Redinus K; Baek JH; Yalamanoglu A; Shin HKH; Moldova R; Harral JW; Swindle D; Pak D; Ferguson SK; Nuss R; Hassell K; Nozik-Grayck E; Palmer AF; Fini MA; Karoor V; Stenmark KR; Buehler PW; Irwin DC
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391342
[TBL] [Abstract][Full Text] [Related]
9. Inflammation, immunological reaction and role of infection in pulmonary hypertension.
Pullamsetti SS; Savai R; Janssen W; Dahal BK; Seeger W; Grimminger F; Ghofrani HA; Weissmann N; Schermuly RT
Clin Microbiol Infect; 2011 Jan; 17(1):7-14. PubMed ID: 20545963
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.
Stenmark KR; Tuder RM; El Kasmi KC
J Appl Physiol (1985); 2015 Nov; 119(10):1164-72. PubMed ID: 25930027
[TBL] [Abstract][Full Text] [Related]
11. CC chemokines Modulate Immune responses in Pulmonary Hypertension.
Yan Q; Liu S; Sun Y; Chen C; Yang Y; Yang S; Lin M; Long J; Lin Y; Liang J; Ai Q; Chen N
J Adv Res; 2023 Nov; ():. PubMed ID: 37926143
[TBL] [Abstract][Full Text] [Related]
12. Inflammation in Pulmonary Arterial Hypertension.
Klouda T; Yuan K
Adv Exp Med Biol; 2021; 1303():351-372. PubMed ID: 33788202
[TBL] [Abstract][Full Text] [Related]
13. New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.
Guignabert C; Tu L; Girerd B; Ricard N; Huertas A; Montani D; Humbert M
Chest; 2015 Feb; 147(2):529-537. PubMed ID: 25644906
[TBL] [Abstract][Full Text] [Related]
14. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.
Pugliese SC; Poth JM; Fini MA; Olschewski A; El Kasmi KC; Stenmark KR
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L229-52. PubMed ID: 25416383
[TBL] [Abstract][Full Text] [Related]
15. The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension.
Kumar R; Mickael C; Chabon J; Gebreab L; Rutebemberwa A; Garcia AR; Koyanagi DE; Sanders L; Gandjeva A; Kearns MT; Barthel L; Janssen WJ; Mauad T; Bandeira A; Schmidt E; Tuder RM; Graham BB
Am J Respir Crit Care Med; 2015 Oct; 192(8):998-1008. PubMed ID: 26192556
[TBL] [Abstract][Full Text] [Related]
16. Inflammation, growth factors, and pulmonary vascular remodeling.
Hassoun PM; Mouthon L; Barberà JA; Eddahibi S; Flores SC; Grimminger F; Jones PL; Maitland ML; Michelakis ED; Morrell NW; Newman JH; Rabinovitch M; Schermuly R; Stenmark KR; Voelkel NF; Yuan JX; Humbert M
J Am Coll Cardiol; 2009 Jun; 54(1 Suppl):S10-S19. PubMed ID: 19555853
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer.
Funk-Hilsdorf TC; Behrens F; Grune J; Simmons S
Front Physiol; 2022; 13():819145. PubMed ID: 35250621
[TBL] [Abstract][Full Text] [Related]
18. Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension.
Stenmark KR; Frid MG; Graham BB; Tuder RM
Cardiovasc Res; 2018 Mar; 114(4):551-564. PubMed ID: 29385432
[TBL] [Abstract][Full Text] [Related]
19. Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling.
Sok MCP; Tria MC; Olingy CE; San Emeterio CL; Botchwey EA
Acta Biomater; 2017 Apr; 53():109-122. PubMed ID: 28213094
[TBL] [Abstract][Full Text] [Related]
20. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension.
Savai R; Pullamsetti SS; Kolbe J; Bieniek E; Voswinckel R; Fink L; Scheed A; Ritter C; Dahal BK; Vater A; Klussmann S; Ghofrani HA; Weissmann N; Klepetko W; Banat GA; Seeger W; Grimminger F; Schermuly RT
Am J Respir Crit Care Med; 2012 Nov; 186(9):897-908. PubMed ID: 22955318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
